You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
I ask your opinion on two stocks which I have held for quite some time, namely IVC and TGR. I had purchased hoping for a reasonable dividend and some capital growth. Your thoughts on retention or sale and investing elsewhere.
Thank you.
A: Thanks for the question.
Both Invocare (IVC) and Tassal (TGR) are well run companies that have delivered strong returns to shareholders.
I don’t have any strong view to say that either is a sell, but on metrics, you could perhaps make a case that divestment of Invocare might be higher up the agenda.
According to FN Arena, the brokers are neutral to marginally negative on Invocare. The target consensus price of $12.88 is below the current market price of $13.49. It is trading on a forecast multiple of 27.3 times FY17 earnings, forecast yield of 3.0%.
Tassal is trading on a multiple of just 13.7 times FY17 earnings, and a forecast yield of 4.1%. The brokers are in the man positive, with the target price of $4.41 compared to the last closing price of $4.15.
Hope this helps.
